SG’s Medtech Startup See-Mode Raises $7m Series A Round Led by Massmutual Ventures

Its latest financing round was backed by existing investors Blackbird Ventures, Cocoon Capital, Entrepreneur First, and SGInnovate, and an angel investor group.

The proceeds will be used to expand product reach to Europe and the US next year as well as to build up R&D, engineering, and sales teams, the statement said. See-Mode’s software technology uses AI and computational models on existing medical imaging technology, such as ultrasounds, CTs, and MRIs, to improve predictions of strokes and vascular diseases in patients.

See-Mode said its first product, Augmented Vascular Analysis (AVA) uses AI software to analyse vascular ultrasound and detect potential strokes in patients. The product has been approved by Singapore’s Health Sciences Authority as a Class B medical device, while US and European approvals are still pending, See-Mode’s website said.

AVA has ongoing pilots in hospitals in Singapore and Australia, the statement said, adding it is already commercially available in the city-state.

Dr Lim Jui, CEO of SGInnovate, a Singapore government-owned entity aimed at supporting deep tech startups, said his organisation would be supporting See-Mode’s team with the company’s development.

“The ability to predict the likelihood of stroke hands the initiative back to doctors, who can introduce pre-emptive countermeasures to prevent stroke occurrence. See-Mode’s ability to secure funding in such a challenging climate is recognition of the value and impact of its suite of products, which not only lead to better care, but also reduce the societal burden of stroke,” he said in the statement.